Comparison of the effects of antithrombotic therapy on delayed bleeding after gastric endoscopic resection: a propensity score-matched case-control study.

[1]  G. Lee,et al.  Efficacy and safety of endoscopic submucosal dissection for gastric neoplasms in patients with compensated liver cirrhosis: a propensity score-matched case-control study. , 2018, Gastrointestinal endoscopy.

[2]  M. Iwamuro,et al.  Postoperative bleeding risk after gastric endoscopic submucosal dissection during antithrombotic drug therapy , 2018, Journal of gastroenterology and hepatology.

[3]  F. Chan,et al.  Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines , 2018, Gut.

[4]  K. Wijarnpreecha,et al.  Heparin-Bridging Therapy and Risk of Bleeding After Endoscopic Submucosal Dissection for Gastric Neoplasms: a Meta-Analysis , 2018, Journal of Gastrointestinal Cancer.

[5]  H. Park,et al.  Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis , 2018, Digestive Diseases and Sciences.

[6]  Xiaoping Zhou,et al.  Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection. , 2017, Gastrointestinal endoscopy.

[7]  K. Hirasawa,et al.  Postoperative bleeding in patients on antithrombotic therapy after gastric endoscopic submucosal dissection , 2017, World journal of gastroenterology.

[8]  Mary B Leonard,et al.  Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. , 2017, Kidney international.

[9]  M. Iwamuro,et al.  Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic submucosal dissection , 2017, Endoscopy International Open.

[10]  D. Murakami,et al.  Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study , 2017, Endoscopy International Open.

[11]  H. Ono,et al.  Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic submucosal dissection? , 2017, Surgical Endoscopy.

[12]  H. Mashima,et al.  Risk factors for postoperative bleeding after gastric endoscopic submucosal dissection in patients under antithrombotics. , 2016, World journal of gastrointestinal endoscopy.

[13]  E. Knight,et al.  Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines , 2016, Gut.

[14]  John A. Evans,et al.  The management of antithrombotic agents for patients undergoing GI endoscopy. , 2016, Gastrointestinal endoscopy.

[15]  G. Lee,et al.  Risk factors and correlations of immediate, early delayed, and late delayed bleeding associated with endoscopic resection for gastric neoplasms , 2016, Surgical Endoscopy.

[16]  G. Lee,et al.  Delayed Bleeding Rate According to the Forrest Classification in Second-Look Endoscopy After Endoscopic Submucosal Dissection , 2015, Digestive Diseases and Sciences.

[17]  K. Koike,et al.  Thienopyridine derivatives as risk factors for bleeding following high risk endoscopic treatments: Safe Treatment on Antiplatelets (STRAP) study , 2015, Endoscopy.

[18]  D. Kikuchi,et al.  Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving antithrombotic therapy , 2015, Gastric Cancer.

[19]  Takuya Yamada,et al.  Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: a propensity score analysis , 2015, Surgical Endoscopy.

[20]  S. Tounou,et al.  Continuous aspirin use does not increase post-endoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy , 2014, Endoscopy International Open.

[21]  O. Yokosuka,et al.  Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents , 2014, BMC Gastroenterology.

[22]  K. Chayama,et al.  Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in patients with chronic kidney disease , 2013, Journal of gastroenterology and hepatology.

[23]  K. Higuchi,et al.  The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection , 2013, BMC Gastroenterology.

[24]  S. Morita,et al.  Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. , 2013, Gastrointestinal endoscopy.

[25]  Takuya Yamada,et al.  Gastric ESD under Heparin Replacement at High-Risk Patients of Thromboembolism Is Technically Feasible but Has a High Risk of Delayed Bleeding: Osaka University ESD Study Group , 2013, Gastroenterology research and practice.

[26]  Ji Won Kim,et al.  Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms? , 2012, Gastrointestinal endoscopy.

[27]  K. Hirata,et al.  Analysis of Delayed Bleeding after Endoscopic Submucosal Dissection for Gastric Epithelial Neoplasms , 2012, Gastroenterology research and practice.

[28]  I. Choi,et al.  Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms , 2012, Endoscopy.

[29]  K. Chayama,et al.  RISK FACTORS FOR BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION OF GASTRIC EPITHELIAL NEOPLASM , 2011, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[30]  G. Lee,et al.  Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. , 2011, Gastrointestinal endoscopy.

[31]  N. Matsuhashi,et al.  Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. , 2010, World journal of gastroenterology.

[32]  D. Graham,et al.  Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions , 2009, Scandinavian journal of gastroenterology.

[33]  G. Raskob,et al.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[34]  M. Jung,et al.  Predictors of immediate bleeding during endoscopic submucosal dissection in gastric lesions , 2008, Surgical Endoscopy.

[35]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.